Literature DB >> 7529552

Cloning and characterization of the t(X;11) breakpoint from a leukemic cell line identify a new member of the forkhead gene family.

P Parry1, Y Wei, G Evans.   

Abstract

Chromosome translocations involving 11q23 are associated with a number of different types of leukemia. These translocations fuse a gene encoding a putative transcription factor, HTRXI, to genes on other chromosomes. We report cloning and sequencing the t(X;11) breakpoint region from a cell line established from an infant with acute lymphocytic leukemia. The gene AFXI, on the X chromosome, is expressed in a variety of cell types. Sequence analysis indicates a high degree of homology between AFXI and the forkhead family of transcription factors. The high degree of identity within the forkhead region and the lack of homology outside that region suggest that AFXI represents a novel forkhead family member. It is predicted that a chimeric fusion protein with altered DNA binding activity will be the result of the translocation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7529552     DOI: 10.1002/gcc.2870110203

Source DB:  PubMed          Journal:  Genes Chromosomes Cancer        ISSN: 1045-2257            Impact factor:   5.006


  38 in total

1.  Functional analysis of the leukemia protein ELL: evidence for a role in the regulation of cell growth and survival.

Authors:  R W Johnstone; M Gerber; T Landewe; A Tollefson; W S Wold; A Shilatifard
Journal:  Mol Cell Biol       Date:  2001-03       Impact factor: 4.272

2.  MSF (MLL septin-like fusion), a fusion partner gene of MLL, in a therapy-related acute myeloid leukemia with a t(11;17)(q23;q25).

Authors:  M Osaka; J D Rowley; N J Zeleznik-Le
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-25       Impact factor: 11.205

Review 3.  The "O" class: crafting clinical care with FoxO transcription factors.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Jinling Hou; Yan Chen Shang
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

4.  Epstein-Barr virus represses the FoxO1 transcription factor through latent membrane protein 1 and latent membrane protein 2A.

Authors:  Angharad M Shore; Paul C White; Rosaline C-Y Hui; Abdelkader Essafi; Eric W-F Lam; Martin Rowe; Paul Brennan
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

5.  Resveratrol up-regulates SIRT1 and inhibits cellular oxidative stress in the diabetic milieu: mechanistic insights.

Authors:  Jung-Mi Yun; Alexander Chien; Ishwarlal Jialal; Sridevi Devaraj
Journal:  J Nutr Biochem       Date:  2011-08-02       Impact factor: 6.048

6.  Mutations of the forkhead/winged-helix gene, FKHL7, in patients with Axenfeld-Rieger anomaly.

Authors:  A J Mears; T Jordan; F Mirzayans; S Dubois; T Kume; M Parlee; R Ritch; B Koop; W L Kuo; C Collins; J Marshall; D B Gould; W Pearce; P Carlsson; S Enerbäck; J Morissette; S Bhattacharya; B Hogan; V Raymond; M A Walter
Journal:  Am J Hum Genet       Date:  1998-11       Impact factor: 11.025

7.  Role of sirtuin histone deacetylase SIRT1 in prostate cancer. A target for prostate cancer management via its inhibition?

Authors:  Brittney Jung-Hynes; Minakshi Nihal; Weixiong Zhong; Nihal Ahmad
Journal:  J Biol Chem       Date:  2008-12-15       Impact factor: 5.157

Review 8.  FoxO tumor suppressors and BCR-ABL-induced leukemia: a matter of evasion of apoptosis.

Authors:  Zainab Jagani; Amrik Singh; Roya Khosravi-Far
Journal:  Biochim Biophys Acta       Date:  2007-10-16

Review 9.  A "FOXO" in sight: targeting Foxo proteins from conception to cancer.

Authors:  Kenneth Maiese; Zhao Zhong Chong; Yan Chen Shang; Jinling Hou
Journal:  Med Res Rev       Date:  2009-05       Impact factor: 12.944

10.  Forkhead box, class O transcription factors in brain: regulation and behavioral manifestation.

Authors:  Abigail Polter; Sufen Yang; Anna A Zmijewska; Thomas van Groen; Ji-Hye Paik; Ronald A Depinho; Stanford L Peng; Richard S Jope; Xiaohua Li
Journal:  Biol Psychiatry       Date:  2008-09-27       Impact factor: 13.382

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.